ID: ALA536275
Chembl Id: CHEMBL536275
PubChem CID: 10481215
Max Phase: Preclinical
Molecular Formula: C28H26ClN3O4
Molecular Weight: 467.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1cccc2c1-c1ccccc1C2=O
Standard InChI: InChI=1S/C28H25N3O4.ClH/c32-25(29-23-10-5-9-22-26(23)20-7-2-3-8-21(20)27(22)33)16-30-14-12-19(13-15-30)31-24-11-4-1-6-18(24)17-35-28(31)34;/h1-11,19H,12-17H2,(H,29,32);1H
Standard InChI Key: DVIGMRVHCMNLPR-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 467.53 | Molecular Weight (Monoisotopic): 467.1845 | AlogP: 4.46 | #Rotatable Bonds: 4 |
| Polar Surface Area: 78.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 12.67 | CX Basic pKa: 6.02 | CX LogP: 3.52 | CX LogD: 3.50 |
| Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.48 | Np Likeness Score: -0.69 |
| 1. Torrens A, Mas J, Port A, Castrillo JA, Sanfeliu O, Guitart X, Dordal A, Romero G, Fisas MA, Sánchez E, Hernández E, Pérez P, Pérez R, Buschmann H.. (2005) Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity., 48 (6): [PMID:15771450] [10.1021/jm049599u] |
Source(1):
